It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

Stock futures are mixed Thursday morning as investors react to a barrage of earnings reports from major companies and important economic indicators.

The pace of economic growth slowed slightly during the fourth quarter. But all things considered, it was still a pretty strong report, suggesting that a robust economy should continue to boost stocks ...

Dan Ives leads technology research at Wedbush Securities and has long been an Nvidia bull. Despite the news out of DeepSeek, Ives remains incredibly optimistic about Nvidia's future and just called ...

In its probe, SEBI observed that funds of credit balance clients were mis-utilized for meeting the obligations of debit balance clients and/or for its own purpose. The amount of misutilization ranged ...

According to Seema Srivastava, Senior Research Analyst at SMC Global Securities, the group’s Q3FY25 quarterly results reflected mixed performance across its subsidiaries.

Finance Minister Nirmala Sitharaman is set to present the Union Budget on February 1, 2025, which plays a crucial role in ...

"2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products ...